Nasus Pharma Ltd.

General ticker "NSRX" information:

  • Sector: Health Care
  • Industry: Medical - Pharmaceuticals
  • Capitalization: $37.0M (TTM average)

Nasus Pharma Ltd. does not follow the US Stock Market performance with the rate: -21.3%.

Estimated limits based on current volatility of 3.6%: low 2.60$, high 2.80$

Factors to consider:

  • Total employees count: 7 as of 2025

Similar symbols

Short-term NSRX quotes

Long-term NSRX plot

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $1.15MM $1.08MM $4.90MM
Operating Income $-1.15MM $-1.08MM $-4.90MM
Non-Operating Income $0.14MM $-0.47MM $-0.90MM
Interest Expense $0.05MM $0.03MM $0.00MM
R&D Expense $0.57MM $0.34MM $2.24MM
Income(Loss) $-1.00MM $-1.55MM $-5.80MM
Net Income(Loss)* $-1.05MM $-1.53MM $-5.86MM
Stockholders Equity $-3.80MM $-3.21MM $2.77MM
Assets $0.44MM $0.72MM $5.00MM
Operating Cash Flow $-1.03MM $-0.67MM $-4.92MM
Capital expenditure $0.00MM $0.00MM $0.01MM
Investing Cash Flow $0.00MM $0.00MM $-3.01MM
Financing Cash Flow $1.05MM $0.77MM $8.92MM
Earnings Per Share** $-0.12 $-0.17 $-0.73

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.